Eventide Gilead Fund C (ETCGX)
53.35
+0.28
(+0.53%)
USD |
Dec 04 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.18% | 3.035B | 0.32% | 60.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -621.55M | 16.19% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital appreciation. The Fund invests primarily in a broad range of equity securities without limitation to market capitalization. The Fund seeks to invest in attractively valued securities that, in its opinion, represent above-average long-term investment opportunities. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Mid-Cap Growth Funds |
| Global Macro | Equity North America |
| US Macro | Mid-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Mid-Cap Funds |
| Fund Owner Firm Name | Eventide |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
64
-357.59M
Peer Group Low
139.02M
Peer Group High
1 Year
% Rank:
83
-621.55M
-6.757B
Peer Group Low
2.780B
Peer Group High
3 Months
% Rank:
66
-1.653B
Peer Group Low
678.25M
Peer Group High
3 Years
% Rank:
83
-14.50B
Peer Group Low
3.982B
Peer Group High
6 Months
% Rank:
71
-3.458B
Peer Group Low
1.405B
Peer Group High
5 Years
% Rank:
75
-20.45B
Peer Group Low
7.569B
Peer Group High
YTD
% Rank:
83
-6.129B
Peer Group Low
2.656B
Peer Group High
10 Years
% Rank:
72
-28.10B
Peer Group Low
7.569B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 05, 2025.
Asset Allocation
As of June 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.47% |
| Stock | 98.62% |
| Bond | 1.18% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.27% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Verona Pharma Plc (DELISTED) | 6.41% | 106.91 | 0.00% |
| Guardant Health, Inc. | 4.29% | 102.01 | -6.00% |
| Toast, Inc. | 3.74% | 35.68 | 1.35% |
| Xometry, Inc. | 3.65% | 59.79 | 2.40% |
| Trane Technologies Plc | 2.98% | 401.17 | -1.03% |
| Mirum Pharmaceuticals, Inc. | 2.61% | 68.50 | -4.24% |
| iRhythm Technologies, Inc. | 2.56% | 178.11 | -1.79% |
| Vistra Corp. | 2.32% | 167.00 | -5.15% |
| Old Dominion Freight Line, Inc. | 2.28% | 155.12 | 1.05% |
| GE Vernova, Inc. | 2.26% | 631.11 | 0.32% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 1.00% |
| Actual Management Fee | 0.97% |
| Administration Fee | 74.28K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | 0.00% |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 50.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital appreciation. The Fund invests primarily in a broad range of equity securities without limitation to market capitalization. The Fund seeks to invest in attractively valued securities that, in its opinion, represent above-average long-term investment opportunities. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Mid-Cap Growth Funds |
| Global Macro | Equity North America |
| US Macro | Mid-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Mid-Cap Funds |
| Fund Owner Firm Name | Eventide |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (12-3-25) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 73 |
| Stock | |
| Weighted Average PE Ratio | 42.87 |
| Weighted Average Price to Sales Ratio | 9.821 |
| Weighted Average Price to Book Ratio | 13.05 |
| Weighted Median ROE | -230.7% |
| Weighted Median ROA | -1.39% |
| ROI (TTM) | 0.37% |
| Return on Investment (TTM) | 0.37% |
| Earning Yield | 0.0288 |
| LT Debt / Shareholders Equity | 1.498 |
| Number of Equity Holdings | 63 |
As of June 30, 2025
Growth Metrics
| EPS Growth (1Y) | 37.79% |
| EPS Growth (3Y) | 18.94% |
| EPS Growth (5Y) | 24.50% |
| Sales Growth (1Y) | 22.21% |
| Sales Growth (3Y) | 22.80% |
| Sales Growth (5Y) | 25.91% |
| Sales per Share Growth (1Y) | 19.00% |
| Sales per Share Growth (3Y) | 20.93% |
| Operating Cash Flow - Growth Rate (3Y) | 52.17% |
As of June 30, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:ETCGX", "name") |
| Broad Asset Class: =YCI("M:ETCGX", "broad_asset_class") |
| Broad Category: =YCI("M:ETCGX", "broad_category_group") |
| Prospectus Objective: =YCI("M:ETCGX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |